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Introduction 
 
Eastern equine encephalitis (EEE) is a serious viral disease of people with 30-50% mortality and 
lifelong neurological disability among many survivors. Historically, in Massachusetts, clusters of 
human cases have occurred over a period of 2-3 years, with a variable number of years between 
clusters. In the years between these case clusters or outbreaks, isolated cases can and do occur. 
Outbreaks of human EEE disease in Massachusetts occurred in 1938-39, 1955-56, 1972-74, 
1982-84, 1990-92, and, 2004-06. Two cases of EEE occurred in both 2010 and 2011; one of the 
cases in each of these years occurred in visitors to Massachusetts.  
 
While the overall number of cases remains small when compared to many other infectious 
diseases and other causes of death or disability, the impact at the individual, family, and 
community levels is significant, and this disease warrants significant public health attention. 
There are multiple agencies and organizations within Massachusetts that cooperate to address 
EEE surveillance and response concerns and activities, and there is a significant amount of local 
expertise and experience. However, in response to indications that risk from EEE may be 
increasing, and a sincere desire to better understand the impact of any changing ecology and 
improve risk mitigation efforts, the Massachusetts Department of Public Health convened a 
panel of external authorities and experts to review and comment on the current EEE surveillance 
and response program. 
Expert Panel 
 
Experts in the fields of mosquito biology, toxicology, ecology, climate change, public health and 
infectious disease were invited to participate. With one exception, the panelists were chosen 
specifically because they were not already involved in the Massachusetts arbovirus surveillance 
and mosquito control processes, and could be expected to provide fresh perspectives. A local 
health agent from southeastern Massachusetts was included to monitor the process and provide 
local context. 
 
 John-Paul Mutebi, PhD: Entomologist, Centers for Disease Control and Prevention,    
Division of Vector-borne Diseases  
 Nicholas Komar, SD: Biologist, Centers for Disease Control and Prevention, Division of 
Vector-borne Diseases  
 Cathleen Drinan, M.Ed.Health Promotion: Health agent, Town of Halifax, MA 
 Richard Primack, PhD: Conservation biologist and plant ecologist, Boston University  
 Barbara Beck, PhD: Toxicology and human health risk assessment consultant, Gradient, 
Cambridge, MA 
 Alan Dupuis, BS: Zoonotic disease research scientist, Arbovirus Laboratories, 
Wadsworth Center, New York State Department of Health  
 Laura Kramer, PhD: Zoonotic disease research scientist, Arbovirus Laboratories, 
Wadsworth Center, New York State Department of Health  
 Marm Kilpatrick, PhD: Disease Ecologist, University of California, Santa Cruz  
 John Howard, DrPH: Research scientist, Arthropod-Borne Disease Program, New York 
State Department of Health (retired) 
 James McGuire, MD: Infectious disease physician, Brigham and Women’s Hospital, 
Boston, MA 
The EEE Expert Panel review process began with a webinar on February 3, 2012 to provide an 
orientation on EEE in Massachusetts and the current surveillance and response system. 
Conference calls were held on February 21, March 8 and 23rd, and April 13.  One call included 
three health agent representatives serving southeastern Massachusetts cities and towns. The 
webinar and conference calls were recorded and audio versions were made available for 
participants to review. The panel’s work was completed during an in-person meeting on April 
23, 2012 from 9-4 PM, hosted by the Massachusetts Commissioner of Public Health, John 
Auerbach. 
 
Initially, the panel was asked to discuss and provide feedback on a specific set of concerns and 
questions, although discussions were not limited to these topics. These questions were: 
 
1. Is there evidence that the historical EEE cycle in Massachusetts has changed; i.e. has there 
been an increase in the frequency of human cases? 
2. If yes, is it attributable to anything specific, such as climate change?  
3. Are there indicators of human risk that we are not utilizing or are under-appreciating? 
4. Is there evidence to support the use of some type of pre-emptive aerial mosquito control 
activity, either larviciding or adulticiding? 
5. What indicators should be used to trigger an aerial adulticide intervention? 
 
During the panel’s considerations, MDPH shared historical surveillance data, performed 
additional data analyses on request and reviewed analyses conducted by panelists. A moderated 
discussion format was used to achieve consensus on panel opinions and recommendations. This 
report summarizes the conclusions reached during these discussions, and also indicates those 
points where complete consensus was not achieved. 
 
Frequency of Human Cases 
 
The number of human cases that occurs during a given outbreak year(s) has decreased 
substantially since the first two outbreaks of disease occurred in 1938 and 1955 (Figure 1). 
However, the average time between outbreak years with multiple cases has also decreased 
(Figure 2). The panel concurred that, over time, the probability that a human EEE case would 
occur in any single year has increased. 
 
The ability to rigorously evaluate whether or not there has been a change in the geographic 
distribution of disease based only on the location of human cases is limited. In the first few 
outbreaks, cases were more likely to be residents of Suffolk, Middlesex and Norfolk counties. 
After 1990, cases are more likely to be Plymouth, and to a lesser extent, Bristol County residents 
(Figure 3). Because cases are recorded based on county of residence and not exposure location, it 
is not clear if this is due to human factors, i.e. Suffolk County residents being exposed to EEE 
virus at their summer residences in southeastern Massachusetts during the middle part of the 20th 
century, or if it represents a true change in the distribution of the EEE virus. However, 
information from the 1938 outbreak (Feemster, 1938) reveals that while equine cases occurred in 
Suffolk, Middlesex and even Worcester and Essex counties, the majority of them were 
distributed throughout Norfolk, Bristol and northern Plymouth counties indicating that 
southeastern Massachusetts is an area of both current and historic risk. 
 
Identification of EEE virus in mosquitoes, animals or humans has occurred sporadically in other 
parts of Massachusetts. However, only the northern portion of Essex County, which borders New 
Hampshire, has shown a period of sustained virus activity. Risk in this area may not correlate 
with risk in southeastern Massachusetts.  
 
An in-depth analysis assessing the relative population abundances of all species of mosquitoes 
by geographic area was strongly recommended by the panel for analyzing virus distribution 
trends. 
 
Causes of Change 
 
On the basis of genetic analyses of EEE virus isolates from Massachusetts performed by MDPH 
and presented to the panel, there was agreement that the observed, underlying pattern of the virus 
cycle has not changed over time; genogroups of the virus are periodically introduced into 
Massachusetts, persist for several years and then disappear (Figures 4 and 5). Human cases do 
not always occur every year a particular genogroup is identified in mosquitoes; however, based 
on the data from 1970-2011, identification of a new genogroup often occurs in conjunction with 
human cases the same year. Currently, no evidence exists that there has been a change in the 
virulence or pathogenicity of the virus, but neither is there sufficient evidence to completely rule 
this out.  Genetic analysis should continue going forward to monitor for the emergence of new 
genogroups and to observe their relationship with the incidence of human disease. Changes in 
virus pathogenicity can and should be investigated simultaneously; this may be most effectively 
done through collaborations with academic institutions or the Centers for Disease Control and 
Prevention. 
 
There was consensus that several elements of the ecologic cycle have not been completely 
elucidated. These uncertainties include:  
 source(s) and timing of introduction of new virus genotypes to Massachusetts;  
 mechanisms of virus persistence from year-to-year also termed “overwintering”;  
 the extinction processes that result in elimination of a particular viral genogroup; and 
 the relative importance of C. melanura (higher infection rate, but low preference for 
feeding on mammals) versus “mammal-biters”, such as Coquellitidia perturbans (low 
preference for birds, but high numbers and preference for mammals) as vectors of EEE to 
humans and other mammals.  
 
Aspects of the ecology of EEE that are more certain and were agreed upon by panel members 
include:  
 identification of Culiseta melanura, a largely bird-biting mosquito whose preferred 
breeding and feeding habitats are white cedar and red maple swamps, as the principle 
vector of EEE virus, responsible for amplification of the virus during the summer;  
 songbirds of various species that live in and around white cedar and red maple 
swamps serve as reservoirs and amplifying hosts of the virus; and 
Susceptible species such as horses, camelids, and humans do not play a role in the virus 
amplification cycle and are considered to be dead-end hosts to the virus.  
 
No clear evidence supporting any single explanation for the observed changes in the frequency 
of occurrence of human cases emerged from the panel discussions. Factors that were considered 
likely to play a contributory role include:  
 evolutions of land use patterns including changes in human population densities adjacent 
to both cedar swamp and cattail marsh mosquito habitats;  
 evolution of land use patterns;  
 alterations in the relative population abundance of particular species of songbirds, 
especially the American robin, and changes in bird migration patterns and seasonal 
timing; 
 changes in average temperatures and precipitation events related to climate change.  
 changes in mosquito abundance, community composition, feeding patterns, or movement 
behavior. 
 
Data exists to further investigate some of these factors and the panel recommended that these 
analyses be pursued. 
 
MDPH surveillance data show evidence of small increases in both C. melanura and Cq. 
perturbans mosquito populations over the last 8 years. The importance of this observation over 
such a short time span is unknown but the panel has suggested analysis of earlier data to further 
evaluate this trend and close observation of the populations moving forward. The in-depth 
analysis recommended previously, looking at the relative population abundances of all species of 
mosquitoes by geographic area, was strongly recommended as a means of analyzing mosquito 
population trends in conjunction with trends in virus distribution. 
 
Human Risk Indicators 
 
In 2011, EEE virus infection was not identified in a mammal prior to the first human infection. 
Although identification of viral spillover into a mammal is indicative of elevated human risk 
from EEE, the panel agreed that lack of an animal case should not preclude an assessment of 
elevated human risk when other indicators are present. 
 
The panel affirmed that MDPH mosquito surveillance does provide an effective way to compare 
abundance of and infection rates in C. melanura from week to week, year to year, and place to 
place. However, these data are limited by variable weather during trap nights, diminishing 
MDPH field staffing resources, and incomplete information on mosquito control activities 
conducted adjacent to traps; the latter two are modifiable factors that the panel recommended 
addressing if possible. In addition, neither mosquito abundance, measured as number of 
mosquitoes per trap per night, nor numbers of infected mosquito pools (grouped samples of up to 
50 mosquitoes) nor infection rates, measured as the minimum number of infected mosquitoes per 
1000, correlate closely enough with the occurrence of human cases (Figures 6,7 and 8). 
Multiplying mosquito abundance by the infection rate creates a new risk indicator called the 
Abundance Infection Factor, AIF, which provides a measure of the density of the infected 
mosquito population. This type of approach has been used for assessing West Nile virus risk and 
has been referred to in the literature as a vector index (Gujaral et al., 2007) or a risk index 
(Kilpatrick et al., 2005). Initial analysis with data from the last eight years indicates that an AIF 
of greater than 40 correlated better with the occurrence of human cases than either of the factors 
on their own (Figure 9). An AIF over 40 aligns with human EEE cases in all but one recent year. 
The panel supported using AIF as the primary risk assessment measure and recommended 
additional analysis to assess the utility of the AIF with the earlier historical data. Going forward, 
the AIF will be employed to better define its use as a tool for predicting human risk. 
 
Other historical indicators of risk that the panel agreed should continue to be evaluated include:  
 above average rainfall in the prior fall and spring,  
 mild winters with insulating snow cover,  
 EEE activity in the previous year,  
 any EEE virus isolations from mosquitoes prior to July 1,  
 isolation of EEE virus from a mammal-biting species of mosquito,  
 infection of a human prior to mid-August, and  
 higher than average summer temperatures which accelerate the mosquito reproductive 
and development cycle and shorten the time interval between a mosquito becoming 
infected with EEE virus and when it becomes capable of transmitting the virus. 
 
Two additional suggestions were to: consider the use of dead bird testing outside of traditional 
areas of EEE activity to evaluate changes in the geographic distribution of the virus; and to 
consider testing mosquito samples for Highlands J virus, as presence of this virus may correlate 
with appearance of EEE virus. These recommendations did not achieve complete consensus from 
the panelists and recent data from New York did not support the utility of Highlands J virus as a 
consistent predictor of EEE risk. 
 
Evidence Regarding Pre-emptive Larviciding or Adulticiding Mosquito Control 
 
The panel agreed on the following points related to larviciding for control of EEE virus. 
Larviciding to kill juvenile C. melanura mosquito stages where they live in water-filled crypts 
under tree roots in white cedar and red maple swamps is difficult. Bti, Bacillus thuringiensis var 
israelensis, a bacteria used as a biological control for many species of mosquito larvae and which 
is widely employed in Massachusetts for larviciding against nuisance mosquito species and those 
that carry West Nile virus, does not penetrate into crypts and is not persistent enough to diffuse 
into them over time. Methoprene, a chemical also used as a larvicide, when applied as a granule 
or pellet, will penetrate the tree canopy of the swamps and is persistent enough to diffuse into 
crypts. However, methoprene’s potential for negative impacts on non-target aquatic makes it 
undesirable for use in sensitive ecologic areas and it is unlikely to be approved for this use in 
environmentally sensitive areas in Massachusetts. 
 
C. melanura remain dormant through the winter (overwinter) as larvae in crypts in the cedar 
swamps. The first generation begins to emerge as adults in late April and that population peaks 
by early June. These adults feed on the birds roosting in and around the swamp and lay the next 
generation of eggs in the crypts. EEE virus is not detected in this generation of mosquitoes, but 
they are important because the population of this generation of mosquitoes will largely determine 
the abundance of second-generation adult mosquitoes later in the season. As the second 
generation of adults emerge in July and August, EEE virus can be isolated from both mosquitoes 
and birds and the amount of virus present increases and remains elevated through August. Both 
mosquito numbers and virus present in the birds and mosquitoes begin to decrease by September, 
although the actual infection rates in older mosquitoes during fall may remain high (Figure 10). 
A logical mosquito control intervention point would seem to be to apply an adulticide before the 
peak of the first generation of mosquitoes to prevent egg-laying and reduce the second 
generation’s population. For maximum effectiveness this intervention would occur during the 
middle of May. However, average night-time temperatures in Massachusetts at that time of year 
are below the 60-64 ºF threshold recommended for the effective application of a mosquito 
adulticide. Application of pyrethroid-based adulticides is effective only when the spray comes 
into direct contact with actively flying mosquitoes and it has no residual effect. The panel 
concluded that pre-emptive adulticide mosquito control applications are not considered practical 
or worthwhile for reducing human risk from EEE in Massachusetts. 
 
Human and Ecological Health Effects of Sumethrin and Piperonyl butoxide (PBO) 
 
During the discussion of mosquito control techniques, a concern was raised about the human and 
ecological health effects of the mosquito adulticide, Anvil®, used in Massachusetts. The United 
States Environmental Protection Agency’s Reregistration Decisions (REDs) for sumethrin and 
piperonyl butoxide (PBO), the active ingredients in Anvil®, were reviewed. Two application 
studies (Peterson et al. 2006; Macedo et al. 2010) that assessed actual deposition of the 
ingredients following aerial and truck-based applications provided additional information. The 
studies evaluated potential human health risks, considering multiple pathways, such as inhalation 
and inadvertant soil ingestion from aerial deposition on soil.  Human health risks were calculated 
using “conservative” exposure assumptions and toxicity criteria, i.e. assumptions that tend to 
overestimate risk.  Moreover, the application rate in these analyses was greater than that 
proposed to be used for aerial spraying in Massachusetts.  When applied in a manner consistent 
with its’ labeling, the panel agreed that the evidence indicates that human exposure to both active 
ingredients falls below levels of concern for all age groups and exposure routes. 
 
Studies do indicate that there are effects on non-target insects associated with these ingredients. 
The panel agreed that widespread adulticiding for disease risk mitigation should be limited to 
public health emergencies. Pesticide application should be done after sunset using ultra-low 
volume applicators to be most effective against the primary vector of EEE virus, Culiseta 
melanura, and to minimize non-target effects.  
 
Triggers for an Aerial Adulticide Intervention 
 
The panel was unanimous in its opinion that it was not possible to prevent every case of human 
illness caused by EEE virus. There was also unanimity that aerial applications of mosquito 
adulticide can be one effective tool employed to reduce, but not eliminate, risk of human EEE 
virus infections, but that aerial spray interventions should not be used in the absence of human 
risk indicators. There was also agreement that personal prevention practices such as repellant 
use, decreased outdoor activity during peak mosquito hours, and clothing to reduce skin 
exposure are effective and should form the basis of all risk reduction efforts. 
 
The panel was not able to recommend precise triggers for determining the need for an aerial 
application of adulticide, in part because of the imperfect nature of indicators of human risk and 
because there were areas identified as needing further evaluation. There was support from the 
panel for the components of the Massachusetts Arbovirus Surveillance and Response Plan as it is 
currently structured; there was also strong support for the suggestion that due to the inability to 
precisely predict risk, that the threshold at which an aerial adulticide intervention is considered 
should be lowered and that aerial spraying of focal areas determined by risk data should be 
considered. There was also strong concern that conducting an aerial adulticide intervention 
would lead to a false sense of security among members of the public, leading to a reduction in 
personal prevention practices. The panel urged that communication messages be structured 
accordingly. 
 
Summary 
 
There should be a general expectation that there will be some risk from EEE virus every year. 
Risk assessments using a combination of historical indicators and newer data analysis techniques 
as endorsed by the panel should be performed. Consideration of the need for aerial adulticiding 
intervention, perhaps in focal areas, should occur before risk levels become critical but should 
not be considered in the absence of indicators of human risk. Personal prevention practices are 
essential for risk reduction and should be incorporated into all risk communication messaging. 
 
 
Addendum 
 
Since October 2011, in addition to the EEE Expert Panel, the Massachusetts Department of 
Public Health has consulted with multiple local health departments, participated in several 
community forums with local officials and responded to requests for information from elected 
officials from southeastern Massachusetts. These discussions have resulted in the following 
recommendations to improve the EEE surveillance and response process. 
 
1. MDPH will seek to improve communications with local health agents through at least 
biweekly conference calls during risk season and through targeted HHAN messages with 
local risk updates. 
2. MDPH will issue specific recommendations for curtailment of outdoor activities near 
dusk for common adoption by affected cities/towns. 
3. MDPH will work with the SRMCB and the MCPs to investigate opportunities to increase 
the frequency of mosquito collections and enhance the timeliness of mosquito collection 
testing by the State Laboratory Institute. 
4. MDPH will explore the utility of new surveillance analyses (3D time/risk mapping; 
Abundance Infection Factor) to current surveillance-based calculations of human risk, 
during 2012.  
5. MDPH will work with agency partners to review rules governing ground spraying to 
more explicitly permit off-road access. 
6. MDPH will lower the threshold for consideration of aerial spraying to mitigate risk of 
human illness in the 2012 Massachusetts Arbovirus Surveillance and Response Plan and 
modify the factors used to define the two highest human risk categories. 
7. MDPH will work with the SRMCB and MCPs to consider options for focal area aerial 
spraying as an alternative to full regional spraying and to explore potential local 
assets/airplane-based equipment to support more rapid and focused spray actions. 
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Figures 
 
Figure 1.  Number of human EEE cases each year from 1938 to 2011. 
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Figure 2. Intervals (in years) between years with any human EEE cases. (Position of circle on x-
axis is the midpoint between years with cases). 
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Figure 3. Percentage of cases by county of residence and year(s) 
 
Year Bristol Middlesex Norfolk Plymouth Suffolk 
1938-39 8% 28% 24% 32% 8%
1955-56 0% 6% 44% 38% 13%
1970 0% 0% 0% 100% 0%
1973-75 0% 20% 60% 20% 0%
1982-84 0% 33% 44% 22% 0%
1990 0% 0% 0% 100% 0%
1992 0% 0% 100% 0% 0%
1997 0% 0% 100% 0% 0%
2000 0% 0% 0% 100% 0%
2004-06 14% 7% 14% 64% 0%
2010-11 50% 0% 0% 50% 0%
 
 
Figure 4. EEE virus genotypes and number of isolates by year.  
 
 
 
 
 
 
 
Figure 5. EEE virus genotypes of human cases, 1968-2011. 
 
 
 
Figure 6. Annual C. melanura minimum infection rates (MIR) from long-term trap sites and   
human EEE cases, 2004-2011 
 
 
 
Figure 7. Number of EEE virus positive mosquito samples (i.e. pools) and number of human 
cases, 1970-September 9, 2011 
  
 
Figure 8. Mean number of C. melanura per trap long-term trap sites and human EEE cases, 
2004-2011 
 
 
 
 
 
 
 
Figure 9. Abundance Infection Factor: Mean number of C. melanura per trap multiplied by the 
annual C. melanura minimum infection rates (MIR) from long-term trap sites and human cases, 
2004-2011. 
 
 
 
 
Figure 10. Culiseta melanura populations and evidence of EEE virus in both mosquitoes and 
birds by month of year (Watts, et al. 1982) 
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